Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.9K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches.

Journal of medical virology·2026
Same author

Diffuse Alveolar Haemorrhage as a Rare Pulmonary Manifestation of Antisynthetase Syndrome: A Case Series.

Journal of clinical medicine·2026
Same author

Clinical Utility of ctDNA Analysis in Lung Cancer-A Review.

Advances in respiratory medicine·2025
Same author

Interaction of Atopy and Airway Dysbiosis Promotes Asthma Persistence in Children With Chronic Rhinosinusitis-5 Years Prospective Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2025
Same author

Safety and Efficacy of Influenza Vaccination in Kidney Graft Recipients in Late Period After Kidney Transplantation.

Vaccines·2025
Same author

Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial.

BMC cancer·2025

Related Experiment Video

Updated: Mar 20, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.8K

Comorbidities in lung cancer.

Agata Ewa Dutkowska1, Adam Antczak

  • 1elesarr@o2.pl.

Pneumonologia I Alergologia Polska
|May 31, 2016
PubMed
Summary

Comorbidity, the presence of additional diseases alongside lung cancer, significantly impacts patient outcomes and complicates treatment. Understanding these co-existing conditions is crucial for effective lung cancer management.

Area of Science:

  • Oncology
  • Epidemiology
  • Internal Medicine

Background:

  • Comorbidity, defined as the presence of one or more additional conditions co-occurring with a primary disease, is common in patients with lung cancer.
  • Lung cancer, the world's most prevalent malignancy, is strongly linked to risk factors like aging and smoking, which are also major contributors to comorbidity.
  • Existing comorbidities can significantly affect the prognosis and treatment strategies for individuals diagnosed with lung cancer.

Purpose of the Study:

  • To elucidate the significance of individual comorbidities in the context of lung cancer.
  • To analyze the impact of various comorbidities on specific lung cancer treatment modalities.
  • To provide a comprehensive overview of comorbidity's role in lung cancer care.

Main Methods:

Keywords:
comorbiditieslung cancer

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

945

Related Experiment Videos

Last Updated: Mar 20, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

945
  • Literature review and synthesis of existing research on lung cancer and comorbidity.
  • Analysis of epidemiological data linking lung cancer, aging, smoking, and comorbid conditions.
  • Evaluation of clinical studies examining the influence of comorbidities on lung cancer treatment outcomes.

Main Results:

  • Specific comorbidities, such as cardiovascular and pulmonary diseases, are frequently observed in lung cancer patients.
  • The presence and type of comorbidity can alter the effectiveness and feasibility of standard lung cancer treatments.
  • Comorbid conditions necessitate tailored treatment approaches to optimize patient prognosis and manage potential complications.

Conclusions:

  • Comorbidity is a critical factor influencing lung cancer prognosis and treatment decisions.
  • A thorough assessment of individual comorbidities is essential for personalized lung cancer management.
  • Further research is warranted to develop evidence-based guidelines for managing comorbidities in lung cancer patients.